Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers
- PMID: 19908235
- PMCID: PMC2868927
- DOI: 10.1002/ajmg.b.31046
Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers
Abstract
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder occurring in male and occasional female carriers of a premutation expansion (55-200 CGG repeats) of the fragile X mental retardation 1 gene (FMR1). This study assessed the relationship between hippocampal volume and psychological symptoms in carriers, both with and without FXTAS, and controls. Volumetric MRI measures, clinical staging, cognitive testing, molecular analysis, and measures of psychological symptoms were performed for female premutation carriers both with FXTAS (n = 16, age: 57.50 + or - 12.46) and without FXTAS (n = 17, age: 44.94 + or - 11.23), in genetically normal female controls (n = 8, age: 50.63 + or - 11.43), male carriers with FXTAS (n = 34, age: 66.44 + or - 6.77) and without FXTAS (n = 21, age: 52.38 + or - 12.11), and genetically normal male controls (n = 30, age: 57.20 + or - 14.12). We examined the relationship between psychological symptom severity and hippocampal volume, as well as correlations with molecular data. We found a significant negative correlation between total hippocampal volume and anxiety in female carriers, with and without FXTAS. This finding was mainly driven by the significant negative correlation between right hippocampal volume and anxiety. Other anxiety-related subscales also correlated with the right hippocampus in females. In male carriers with and without FXTAS, only paranoid ideation negatively correlated with hippocampal volume. Female premutation carriers demonstrated a negative association between hippocampal volume and the severity of anxiety-related psychological symptoms. Though the presentation of FXTAS symptoms is less common in females, anxiety-related problems are common both prior to and after the onset of FXTAS, and may be related to hippocampal changes.
Figures
References
-
- Adams JS, Adams PE, Nguyen D, Brunberg JA, Tassone F, Zhang W, Koldewyn K, Rivera SM, Grigsby J, Zhang L, et al. Volumetric brain changes in females with fragile X-associated tremor/ataxia syndrome (FXTAS) Neurology. 2007;69(9):851–859. - PubMed
-
- Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJA, Yang KT, Lee C, Hudson R, Gorwill RH, Nolin SL, Glicksman A, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: The international collaborative POF in fragile X study— Preliminary data. Am J Med Genet. 1999;83:322–325. - PMC - PubMed
-
- Arocena DG, Iwahashi CK, Won N, Beilina A, Ludwig AL, Tassone F, Schwartz PH, Hagerman PJ. Induction of inclusion formation and disruption of lamin A/C structure by premutation CGG-repeat RNA in human cultured neural cells. Hum Mol Genet. 2005;14(23):3661–3671. - PubMed
-
- Bacalman S, Farzin F, Bourgeois JA, Cogswell J, Goodlin-Jones BL, Gane LW, Grigsby J, Leehey MA, Tassone F, Hagerman RJ. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: Newly described fronto-subcortical dementia. J Clin Psychiatry. 2006;67(1):87–94. - PubMed
-
- Bannerman DM, Grubb M, Deacon RM, Yee BK, Feldon J, Rawlins JN. Ventral hippocampal lesions affect anxiety but not spatial learning. Behav Brain Res. 2003;139(1–2):197–213. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HD36071/HD/NICHD NIH HHS/United States
- K23 MH077554/MH/NIMH NIH HHS/United States
- RR024922/RR/NCRR NIH HHS/United States
- RL1AG032119/AG/NIA NIH HHS/United States
- R01 NS044299/NS/NINDS NIH HHS/United States
- P30 AG1029/AG/NIA NIH HHS/United States
- RL1AG032115/AG/NIA NIH HHS/United States
- R01 HD036071/HD/NICHD NIH HHS/United States
- P30 AG10129/AG/NIA NIH HHS/United States
- AG032115/AG/NIA NIH HHS/United States
- P30 HD002274/HD/NICHD NIH HHS/United States
- R01 MH078041/MH/NIMH NIH HHS/United States
- MH078041/MH/NIMH NIH HHS/United States
- UL1 DE019583/DE/NIDCR NIH HHS/United States
- RL1 NS062412/NS/NINDS NIH HHS/United States
- MH77554/MH/NIMH NIH HHS/United States
- HD02274/HD/NICHD NIH HHS/United States
- UL1 RR024922/RR/NCRR NIH HHS/United States
- RL1 AG032119/AG/NIA NIH HHS/United States
- NS044299/NS/NINDS NIH HHS/United States
- UL1DE019583/DE/NIDCR NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
- RL1 AG032115/AG/NIA NIH HHS/United States
- NS062412/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
